| Colleen Anhalt, | |
|
1223 Madison St, Beaver Dam, WI 53916-2629 | |
| (920) 885-4750 | |
| (920) 885-3839 |
| Full Name | Colleen Anhalt |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1223 Madison St, Beaver Dam, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285997536 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3675-154 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Colleen Anhalt, 1223 Madison St, Beaver Dam, WI 53916-2629 Ph: (920) 885-4750 | Colleen Anhalt, 1223 Madison St, Beaver Dam, WI 53916-2629 Ph: (920) 885-4750 |
News Archive
The development of nano-biosensors and nanoparticle-based vaccines and medicines has opened a new path toward better management of the coronavirus disease 2019 (COVID-19) pandemic. In a recently published article in the journal ACS Biomaterials Science & Engineering, scientists have reviewed recent advancements in nanotechnology-based diagnostic and therapeutic interventions against human coronaviruses.
Scientists at St. Jude Children's Research Hospital have shown that cell-free DNA from cerebrospinal fluid (CSF) can be used to detect measurable residual disease (MRD) in children treated for the brain tumor medulloblastoma.
Biogen Idec and Swedish Orphan Biovitrum AB today announced results from a Phase 1/2a open-label, dose-escalation, safety and pharmacokinetic study of the companies' long-lasting, fully-recombinant factor IX Fc fusion protein (rFIXFc) in hemophilia B patients. The data, which were presented at the World Federation of Hemophilia Congress in Buenos Aires, Argentina, on July 11, 2010, showed that rFIXFc was well tolerated and demonstrated an approximately three-fold increase in half-life compared to historical data for existing therapies.
All current breast cancer drugs were first tested in cell lines. Each cell line began as cancer in a patient. As such, each cell line is a surrogate for that patient's disease.
› Verified 9 days ago
Ms. Emily M Neuman, M.S. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1223 Madison St, Beaver Dam, WI 53916 Phone: 920-885-4750 | |
Angela Kay Van Ooyen, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1223 Madison St, Beaver Dam, WI 53916 Phone: 920-885-4750 Fax: 920-885-3839 | |
Kali Lynn Shine, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1223 Madison St, Beaver Dam, WI 53916 Phone: 920-885-4750 | |
Mrs. Mary Leigh Kirschbaum, M.S./CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 410 Roedl Court, Golden Living Center, Beaver Dam, WI 53916 Phone: 920-887-7191 Fax: 920-887-7270 | |
Courtney Rae Retzlaff, M.S. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 104 Fakes Ct., Beaver Dam, WI 53916 Phone: 715-923-7014 | |
Mrs. Jacqueline Maud Davis, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1223 Madison St, Beaver Dam, WI 53916 Phone: 920-885-4750 |